The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
108921619 10892161 9 F 2015 20160630 20150306 20160707 EXP CA-PFIZER INC-2014329514 PFIZER 32.00 YR F Y 0.00000 20160707 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
108921619 10892161 1 PS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 20 MG, WEEKLY (8 TABLETS OF 2.5 MG) Y 11719 20 MG TABLET /wk
108921619 10892161 2 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 20 MG, WEEKLY (8 TABLETS OF 2.5 MG)UNK Y 11719 20 MG TABLET /wk
108921619 10892161 3 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 20 MG, WEEKLY (8 TABLETS OF 2.5 MG) Y 11719 20 MG TABLET /wk
108921619 10892161 4 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 20 MG, WEEKLY (8 TABLETS OF 2.5 MG) Y 11719 20 MG TABLET /wk
108921619 10892161 5 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 20 MG, WEEKLY (8 TABLETS OF 2.5 MG) Y 11719 20 MG TABLET /wk
108921619 10892161 6 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 25 MG, WEEKLY 11719 25 MG /wk
108921619 10892161 7 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 25 MG, WEEKLY 11719 25 MG /wk
108921619 10892161 8 SS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, 2X/DAY Y 203214 5 MG TABLET BID
108921619 10892161 9 SS SULFASALAZINE. SULFASALAZINE 1 500 MG, UP TO 1G 2X/DAY Y 7073
108921619 10892161 10 SS ACTEMRA TOCILIZUMAB 1 UNK Y 0
108921619 10892161 11 SS HUMIRA ADALIMUMAB 1 UNK Y 0
108921619 10892161 12 SS LEFLUNOMIDE. LEFLUNOMIDE 1 20 MG, 1X/DAY Y 0 20 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
108921619 10892161 1 Rheumatoid arthritis
108921619 10892161 6 Rheumatoid arthritis
108921619 10892161 8 Rheumatoid arthritis
108921619 10892161 9 Rheumatoid arthritis
108921619 10892161 10 Rheumatoid arthritis
108921619 10892161 11 Rheumatoid arthritis
108921619 10892161 12 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
108921619 10892161 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
108921619 10892161 Animal bite
108921619 10892161 Arthropathy
108921619 10892161 Diarrhoea
108921619 10892161 Disease progression
108921619 10892161 Drug ineffective
108921619 10892161 Migraine
108921619 10892161 Osteoporosis
108921619 10892161 Rheumatoid arthritis
108921619 10892161 Treatment failure
108921619 10892161 Upper limb fracture
108921619 10892161 Wound infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
108921619 10892161 1 20120412 0
108921619 10892161 2 20130509 0
108921619 10892161 3 20130808 0
108921619 10892161 4 20150415 0
108921619 10892161 5 20150617 0
108921619 10892161 6 200308 0
108921619 10892161 7 20140910 0
108921619 10892161 8 20150109 2015 0
108921619 10892161 9 200003 200308 0
108921619 10892161 10 2010 2015 0
108921619 10892161 11 2005 2010 0
108921619 10892161 12 200408 200409 0